Scott M. Plesha
Net Worth

Last updated:

What is Scott M. Plesha net worth?

The estimated net worth of Mr. Scott M. Plesha is at least $6,323,597 as of 31 Jan 2022. He owns shares worth $1,308,077 as insider, has earned $609,300 from insider trading and has received compensation worth at least $4,406,220 in BioDelivery Sciences International, Inc..

What is the salary of Scott M. Plesha?

Mr. Scott M. Plesha salary is $629,460 per year as Pres & Chief Commercial Officer in BioDelivery Sciences International, Inc..

How old is Scott M. Plesha?

Mr. Scott M. Plesha is 60 years old, born in 1965.

What stocks does Scott M. Plesha currently own?

As insider, Mr. Scott M. Plesha owns shares in one company:

Company Title Shares Price per share Total value
BioDelivery Sciences International, Inc. (BDSI) Pres & Chief Commercial Officer 234,003 $5.59 $1,308,077

What does BioDelivery Sciences International, Inc. do?

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

BDSI logo
BDSI
BioDelivery Sciences International, Inc.
$5.59

Scott M. Plesha insider trading

BioDelivery Sciences International, Inc.

Mr. Scott M. Plesha has made 5 insider trades between 2018-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 50,000 units of BDSI stock on 11 Dec 2019. As of 31 Jan 2022 he still owns at least 234,003 units of BDSI stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 24,203 N/A N/A
Option
Restricted Stock Units 45,253 N/A N/A
Option
Common Stock 21,050 N/A N/A
Option
Restricted Stock Units 20,834 N/A N/A
Option
Common Stock 20,834 N/A N/A
Option
Common Stock 13,333 N/A N/A
Option
Restricted Stock Units 13,333 N/A N/A
Option
Common Stock 10,870 N/A N/A
Option
Restricted Stock Units 10,870 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 $3.55 $53,250
Option
Common Stock 29,167 N/A N/A
Option
Restricted Stock Units 8,334 N/A N/A
Option
Common Stock 29,167 N/A N/A
Option
Common Stock 13,333 N/A N/A
Option
Restricted Stock Units 13,333 N/A N/A
Sale
Common Stock 15,000 $5.77 $86,550
Sale
Common Stock 50,000 $6.36 $318,000
Sale
Common Stock 25,000 $6.06 $151,500
Option
Common Stock 29,166 N/A N/A
Option
Restricted Stock Units 29,166 N/A N/A
Option
Restricted Stock Units 11,666 N/A N/A
Option
Common Stock 11,666 N/A N/A
Option
Common Stock 36,432 N/A N/A
Option
Restricted Stock Units 36,432 N/A N/A
Option
Restricted Stock Units 8,333 N/A N/A
Option
Common Stock 8,333 N/A N/A
Option
Restricted Stock Units 11,667 N/A N/A
Option
Common Stock 11,667 N/A N/A

BioDelivery Sciences International key executives

BioDelivery Sciences International, Inc. executives and other stock owners filed with the SEC: